α-Particle Radioimmunotherapy of Disseminated Peritoneal Disease Using a <sup>212</sup> Pb-Labeled Radioimmunoconjugate Targeting HER2
2005 · Cancer Biotherapy and Radiopharmaceuticals · 99 citations
https://doi.org/10.1089/cbr.2005.20.557
D
Diane E. Milenic
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
128
Papers
7.1K
Citations
50
h-index
100
i10-index
Diane E. Milenic is an academic researcher. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Monoclonal and Polyclonal Antibodies Research & Medical Imaging Techniques and Applications. The author has an h-index of 50, co-authored 109 publications.
Papers by this author
worksPotentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease
2007 · Clinical Cancer Research · 75 citations
https://doi.org/10.1158/1078-0432.ccr-06-2300
Improved efficacy of α‐particle–targeted radiation therapy
2010 · Cancer · 53 citations
https://doi.org/10.1002/cncr.24793
212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
2013 · British Journal of Cancer · 26 citations
https://doi.org/10.1038/bjc.2013.189
Evaluation of Platinum Chemotherapy in Combination with HER2-Targeted α-Particle Radiation
2013 · Cancer Biotherapy and Radiopharmaceuticals · 24 citations
https://doi.org/10.1089/cbr.2012.1423
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
2017 · Translational Oncology · 23 citations
https://doi.org/10.1016/j.tranon.2017.04.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat